Similar articles

• [Late complications after treatment of Hodgkin's disease].

  Lund MB, Kongerud J, Boe J, Ihlen H, Forfang K, Abrahamsen AF, Nome O. Lund MB, et al. Tidsskr Nor Laegeforen. 1999 Mar 10;119(7):933-7. Tidsskr Nor Laegeforen. 1999. PMID: 10210953 Norwegian.
• Late effects of Hodgkin's disease and its treatment.

  Ng AK, Mauch PM. Ng AK, et al. Cancer J. 2009 Mar-Apr;15(2):164-8. doi: 10.1097/PPO.0b013e31819e30d7. Cancer J. 2009. PMID: 19390314 Review.
• Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.

  Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M. Brusamolino E, et al. Clin Cancer Res. 2006 Nov 1;12(21):6487-93. doi: 10.1158/1078-0432.CCR-06-1420. Clin Cancer Res. 2006. PMID: 17085663
• The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

  Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Brusamolino E, et al. Haematologica. 1998 Sep;83(9):812-23. Haematologica. 1998. PMID: 9825578
• [Late treatment related complications of Hodgkin's disease].

  Henry-Amar M, Gisselbrecht C. Henry-Amar M, et al. Rev Prat. 1998 May 15;48(10):1092-7. Rev Prat. 1998. PMID: 9781154 Review. French.